Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

86 results about "Alpha ketoglutarate" patented technology

Intermediate in the Krebs' cycle; also produced from glutamate in amino group transfer reactions and by oxidative deamination.

Method for microbial fermentation synthesis of ª‡- ketoglutaric acid

InactiveCN1544642AIncrease carbon molar ratioIncrease concentrationFermentationHigh concentrationIncreased biotin
The invention is a method of synthesizing alpha-ketoglutarate by fermenting microbes, promoting to produce a large amount of alpha-ketoglutarate in fermenting course by adding CaCO3 to the culture medium and increasing biotin concentration. in the course of fermenting candida glabrata CCTCC M202019 to producing pyruvic acid, the delay of time of adding CaCO3 will inhibit the generation of alpha-ketoglutarate and increase the carbon mole ratio of pyruvic acid to alpha-ketoglutarate (CPYR/CKG), and increase of CaCO3 concentration in the culture medium will promote accumulation of a large amount of alpha-ketoglutarate, when the CaCO3 concentration is 40g/L, it is most beneficial to alpha-ketoglutarate generation. Keeping the CaCO3 concentration in the culture medium but increasing biotin concentration in the culture medium so as to promote the continuous increase of the alpha-ketoglutarate concentration but continuous decrease of CPYR/ CKG value, and when biotin concentration is 60mum g/L, accumulated quantity of alpha- ketoglutarate is 23.5g/L. when Ca2+ exists, in-cell phosphoenolpyruvate carboxylase activity can be increased by 40%, and the activity of pyruvic acid dehydrogenase system does not change obviously. The increase of the Ca2+ and biotin concentration can remarkably the activity of enhance pyruvic acid dehydrogenase, thus making T.glabrata transfer from production of pyruvic acid by fermenting to synthesis of high-concentration alpha-ketoglutarate.
Owner:JIANGNAN UNIV

Method for separating alpha-ketoglutaric acid from conversion solution

The invention discloses a method for separating alpha-ketoglutaric acid from a conversion solution, which comprises the following steps: sequentially carrying out ceramic filtration, ultrafiltration and reverse osmosis on the conversion solution to obtain an alpha-ketoglutaric acid concentrated solution; reacting the obtained concentrated solution with calcium superchloride, and filtering to obtain alpha-ketoglutarate; adding the alpha-ketoglutarate and ethanol into a reaction kettle, slowly and dropwisely adding sulfuric acid, stopping adding the acid when the pH value of the ethanol solution is 1.3-1.5, stirring to react to generate a calcium sulfate precipitate, filtering, and collecting the filtrate which is a ketoglutaric acid ethanol solution; eluting the residual alpha-ketoglutaric acid from the calcium sulfate with ethanol, and collecting the eluting solution; and mixing the filtrate and eluting solution, and heating and concentrating under reduced pressure to precipitate the alpha-ketoglutaric acid crystal. The membrane filtration technique is adopted to avoid abundant water evaporation; and thus, the method has the advantages of energy saving, high production yield, favorable crystal form, light color of the crystal grain, and stable product quality, and can easily implement industrialized large-scale production.
Owner:JING JING PHARMA

Method by using co-expression recombinant bacteria strain to convert and produce alpha-ketoglutarate

ActiveCN107686850AHigh yieldSolve the problem that a large amount of catalase needs to be added from an external sourceBacteriaMicroorganism based processesEscherichia coliStreptomyces
The invention discloses a method by using a co-expression recombinant bacteria strain to convert and product alpha-ketoglutarate, and belongs to the technical field of biology. The method is characterized in that novel L-glutamic oxidase is screened from streptomycete and is induced to express and purify in escherichia coli, and the enzymatic property is studied; when the pH (potential of hydrogen) value is 5.5 to 7.0, the enzyme has higher activity, the most suitable reaction temperature is 30 to 45 DEG C, Vmax is 100 to 150U / mg, and Km is 8 to 10mM; the original gene sequence of the L-glutamic oxidase is subject to codon optimization, and the plasmid co-expression with a catalase gene from the escherichia coli is performed, so as to construct the co-expression recombinant bacteria strain; the recombinant bacteria strain is used as a whole-cell catalyst to convert the L-glutamic acid (salt), the output of alpha-ketoglutarate reaches 76.08g / L after reacting for 9h, and the molar conversion rate is 96.8%. The method has the advantages that the problems of complicated production steps, low yield, pollution to environment and the like in the alpha-ketoglutarate production process aresolved, the high-yield and one-step type production of the alpha-ketoglutarate is realized, and the industrial application value is higher.
Owner:TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI

Method for realizing excessive accumulation of alpha-ketoglutarate acid by adding alpha-ketoglutarate acid dehydrogenase inhibitor

InactiveCN101250563AImproved compared to the controlMicroorganism based processesFermentationTorulopsis glabrataCarbon metabolism
The invention relates to a method for adding alpha-ketoglutarate dehydrogenase inhibitor to realize excessive accumulation of alpha-ketoglutaric acid, which belongs to the technical field of the metabolic regulation optimized fermentation process of the protein level. The method of the invention comprises following steps: utilizing multi - vitamin - auxotrophic yeast of Torulopsis glabrata CCTCC M202019 as producing strains, regulating the activity of alpha-ketoglutarate dehydrogenase through adding the alpha-ketoglutarate dehydrogenase inhibitor: hydrogen peroxide, methotrexate, sodium hypochlorite or hydroxyamino in culture medium, purposively lowing the activity of the alpha-ketoglutarate dehydrogenase, reducing the degradation of the alpha-ketoglutaric acid in the metabolic process, and achieving the aim of the excessive accumulation of the alpha-ketoglutaric acid. The method of the invention cuts off carbon metabolism flow on a node of the alpha-ketoglutaric acid through regulating the stream distribution of carbon metabolism and the carbon metabolism flow, wherein the maximum output of the alpha-ketoglutaric acid reaches 23.2g / L, which is increased by 12.2% compared with the control. The invention provides a new thought for the fermentation research of TCA cycle intermediate metabolite.
Owner:GUANGDONG HUANXI BIOLOGICAL TECH

Process for preparing L-arginine-alpha-ketoglutarate (AAKG) from fermentation liquor through direct crystallization

The invention belongs to the technical field of biopharmaceuticals and relates to a method for preparing L-arginine-alpha-ketoglutarate (AAKG) from raw materials comprising L-arginine and alpha-ketoglutarate obtained by fermentation. In the method, the L-arginine and alpha-ketoglutarate in the fermentation liquor are directly used as the raw materials for AAKG rather than being used for extracting the refined crystalline products. The process mainly comprises the following technical steps: fermentation liquor pretreatment, chelation, concentration, crystallization, dissolution for decolorization, recrystallization, drying and the like. The process is characterized by comprising the following steps: pretreating the fermentation liquor with L-arginine, adding a certain amount of fermentation filtrate with alpha-ketoglutarate to the pretreated fermentation liquor to be chelated, carrying out vacuum evaporation concentration and then cooling the crystal to obtain the coarse product; and recrystallizing the coarse product by utilizing an organic solvent to obtain the high-purity product. The process has the advantages of high product purity, short flow, obvious emission reduction effect and the like, and is easy for quality control. The AAKG is mainly used as a physique enhancer and has the functions of promoting the muscles to grow and recover rapidly, promoting liver cells to absorb the nutrients and energy, maintaining normal liver functions and the like.
Owner:FUJIAN GUTIAN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products